Charcot-Marie-Tooth neuropathy type 1C (CMT1C) is a rare, inherited nerve disease. It mainly damages the peripheral nerves, which are the long nerves that carry signals between the spinal cord and the arms and legs. “Type 1” means it is a demyelinating neuropathy, so the myelin (the insulating coating around nerves) is mainly affected. In CMT1C, the nerve signals travel more slowly, so muscles in the feet, legs, hands, and sometimes arms become weak and thin over many years. Sensation (feeling of touch, pain, temperature, vibration) is also reduced, especially in the feet and hands. CMT1C is usually mild to moderate and often starts in childhood or early adult life.GARD Information Center+2Monarch Initiative+2
Charcot-Marie-Tooth neuropathy type 1C (CMT1C) is a rare, inherited nerve disease that mainly affects the long nerves in the arms and legs. It belongs to the “demyelinating” CMT1 group, which means the insulating layer (myelin) around the nerves is damaged, so signals travel slowly. Most people develop symptoms such as weakness of the feet and hands, high-arched feet, and balance problems, usually starting in childhood or early adult life.PubMed+1
CMT1C is autosomal dominant. This means a change (mutation) in only one copy of a specific gene is enough to cause the disease. The main gene known for CMT1C is called LITAF (lipopolysaccharide-induced tumor necrosis factor factor) on chromosome 16. A person with CMT1C has a harmful mutation in LITAF. That mutation leads to abnormal LITAF protein inside Schwann cells, the cells that make myelin. Over time, the myelin around the peripheral nerves becomes unstable and damaged. This causes slow nerve conduction, weakness, and sensory loss.Wiley Online Library+2Monarch Initiative+2
CMT1C belongs to the larger Charcot-Marie-Tooth (CMT) disease group. CMT is one of the most common hereditary peripheral neuropathies. All CMT types cause slowly progressive weakness and wasting in the distal (far) parts of the limbs, such as the feet and hands, with mild to moderate loss of sensation. CMT1C is one of the rarer subtypes within CMT1.NCBI+2Springer+2
Other names
Charcot-Marie-Tooth neuropathy type 1C is known by several other names in the medical literature. All these names describe the same or very closely related condition:
-
Charcot-Marie-Tooth disease type 1C
-
CMT1C
-
Charcot-Marie-Tooth disease, demyelinating, type 1C
-
Hereditary motor and sensory neuropathy type 1C (HMSN 1C)
-
Neuropathy, hereditary motor and sensory, type 1C
-
Demyelinating Charcot-Marie-Tooth neuropathy due to LITAF mutation
-
CMT, slow nerve conduction type C
These different names reflect the same ideas: it is a hereditary (passed in families), motor and sensory (affects movement and feeling), demyelinating (myelin damage) neuropathy of CMT type 1, and it is linked to changes in the LITAF gene.MIPS+2Monarch Initiative+2
Types and subtypes
Doctors mainly use “CMT1C” as one clinical type. However, within CMT1C there can be variation in how severe it is and how it shows in each person. It is helpful to think of several practical “sub-patterns,” even if they are not official separate diseases:GARD Information Center+1
-
Classic CMT1C pattern – This pattern looks like typical CMT1. There is distal leg weakness, thin lower legs, high arches, hammertoes, and sensory loss in the feet. Symptoms often start in childhood or teen years, and walking becomes clumsy or slow over time.
-
Mild predominantly sensory pattern – Some people have mainly sensory problems such as tingling, numbness, and burning pain in the feet or hands. Muscle weakness is mild or almost absent. These patients may notice difficulty with balance or fine touch rather than obvious weakness.
-
Late-onset mild CMT1C – In a few people, symptoms begin in mid-life or later. Weakness and sensory changes progress slowly. These individuals may be misdiagnosed early as having “idiopathic” peripheral neuropathy until genetic testing finds a LITAF mutation.
-
Childhood-onset CMT1C – In some families, children show delayed motor milestones (for example, late to walk, poor running, frequent falling). Foot deformities may appear early. Nerve conduction studies show demyelination.
-
CMT1C with marked foot deformities – Pes cavus (high arches), hammertoes, and other foot alignment problems can be very prominent and may need orthotics or surgery.
-
CMT1C with hand tremor – Some patients have an action tremor in the hands. The hands shake when they try to hold or reach for objects. This tremor can be a notable feature in some families.GARD Information Center+1
-
CMT1C overlapping with other CMT1 features – Because CMT1C is clinically similar to CMT1A and other CMT1 forms, some people are first labelled as “CMT1” without a specific subtype until genetic testing confirms LITAF involvement.PubMed+1
These patterns are all caused by the same basic mechanism – a mutation in LITAF – but they help clinicians describe the range of severity and symptoms in everyday practice.
Causes
It is important to say clearly that the main root cause of CMT1C is a pathogenic mutation in the LITAF gene. All other “causes” listed here are really mechanisms, risk factors, or influences that explain how and why that mutation leads to the disease or affects its severity.Wiley Online Library+1
-
Pathogenic LITAF gene mutation – A harmful change in the DNA code of the LITAF gene changes the structure or function of the LITAF protein. This abnormal protein cannot do its normal job in Schwann cells, leading to demyelination and neuropathy.Wiley Online Library+1
-
Autosomal dominant inheritance – Because the condition is autosomal dominant, a person who inherits one mutated copy of LITAF from an affected parent has a high chance of developing CMT1C. Each child of an affected parent has a 50% chance of inheriting the mutation.Wiley Online Library+1
-
De novo mutation – Sometimes the LITAF mutation appears for the first time in a child, even when neither parent has CMT. This is called a de novo mutation. After this, the mutation can be passed to future generations in the usual autosomal dominant way.Muscular Dystrophy New Zealand –+1
-
Missense changes in key regions of LITAF – Many known CMT1C mutations are missense mutations (one amino acid in the protein is changed). If this change happens in a very important part of the LITAF protein, it can strongly disrupt its behaviour and cause disease.Wiley Online Library+1
-
Abnormal protein folding – Some LITAF mutations cause the protein to fold incorrectly. Misfolded proteins may be trapped in the wrong part of the cell or may clump together. This stresses the Schwann cell and disturbs normal myelin maintenance.Wiley Online Library+1
-
Disrupted endosomal–lysosomal trafficking – LITAF is involved in the endosomal–lysosomal system, which handles cell waste and membrane recycling. Mutations may impair this system, so waste products and damaged proteins are not cleared properly, harming Schwann cells and myelin.Wiley Online Library+1
-
Demyelination of peripheral nerves – Damaged Schwann cells cannot maintain healthy myelin. Patches of myelin are lost (segmental demyelination), leading to slow nerve conduction and nerve fibre damage, which cause weakness and sensory loss.NCBI+1
-
Abnormal remyelination and “onion bulb” formation – The body tries to repair demyelinated nerves by remyelinating them. Repeated cycles of demyelination and remyelination cause layers of Schwann cell processes to wrap around axons, forming “onion bulb” structures seen on nerve biopsy. This is a typical feature of CMT1.NCBI+1
-
Chronic axonal damage secondary to demyelination – Over many years, the axons themselves become damaged because of long-lasting demyelination. This axonal loss adds to the weakness and sensory loss, especially in older adults with CMT1C.NCBI+1
-
Modifier genes – Other genes in a person’s genome may slightly increase or decrease the impact of the LITAF mutation. This is one reason why severity can be very different even within the same family.NCBI+1
-
Epigenetic factors – Chemical marks on DNA and histones can change how strongly genes are expressed without changing the DNA sequence. These epigenetic changes may influence how much LITAF or related proteins are produced and may modify disease severity.Dove Medical Press
-
Age-related nerve vulnerability – Peripheral nerves naturally face wear and tear as people age. In someone with a LITAF mutation, this normal aging adds to existing weakness and sensory loss, so symptoms slowly worsen over decades.NINDS+1
-
Mechanical stress on long nerves – The longest nerves, which go to the feet and hands, are most stressed. In CMT1C these nerves are already vulnerable, so everyday mechanical strain and stretching may contribute to gradual worsening of function.NINDS+1
-
Metabolic stresses (e.g., diabetes) – If a person with CMT1C also develops diabetes or other metabolic conditions that harm nerves, these extra factors can worsen neuropathy. The LITAF mutation remains the main cause, but co-existing illnesses add extra stress.ARUP Consult+1
-
Nutritional deficiencies – Deficiencies of vitamin B12, folate, or other nutrients do not cause CMT1C, but they can worsen neuropathy in someone who already has it. Correcting these deficiencies may help prevent extra damage.NCBI+1
-
Physical inactivity – CMT1C itself causes weakness and fatigue, which may reduce physical activity. Low activity further weakens muscles and joints. This is not a primary cause of CMT1C but can increase disability over time.NINDS+1
-
Obesity and joint strain – Excess body weight increases stress on feet, ankles, and knees in people who already have weak muscles and deformed feet. This can worsen pain, balance problems, and walking difficulty.NINDS+1
-
Neurotoxic medications – Some chemotherapy drugs and certain other medicines can injure peripheral nerves. In a person with CMT1C, these drugs may cause extra neuropathy on top of the inherited problem.医生 should consider this when choosing treatments.NCBI+1
-
Alcohol misuse – Heavy, long-term alcohol intake can damage peripheral nerves. In someone with CMT1C, alcohol-related nerve damage can worsen symptoms, although it does not create CMT1C by itself.NCBI+1
-
Environmental nerve toxins – Long-term exposure to some industrial chemicals or heavy metals may harm peripheral nerves. This does not cause the LITAF mutation, but it can add additional nerve damage in a person who already has CMT1C, increasing weakness and numbness.ARUP Consult+1
Symptoms and signs
CMT1C shares many symptoms with other CMT1 types. The severity can vary widely, even inside one family.GARD Information Center+1
-
Distal leg weakness – The muscles below the knees, especially the muscles that lift the foot, become weak. The calves may look thin over time. This makes running and climbing stairs more difficult.Mayo Clinic+1
-
Foot drop – Because of weakness in the ankle dorsiflexor muscles, the front of the foot does not lift well during walking. The toes may drag on the ground. Many people lift their knees higher (“steppage gait”) to avoid tripping.Mayo Clinic+1
-
Pes cavus (high foot arches) – The arches of the feet become very high. The heel may tilt inwards, and the toes may curl. This foot shape is typical in CMT and can cause pain, calluses, and difficulty finding comfortable shoes.GARD Information Center+1
-
Hammertoes – The toes bend at the middle joints and become fixed in a claw-like position. This can rub inside shoes and cause pressure sores or corns.Mayo Clinic+1
-
Gait difficulties and frequent falls – Because of weakness, foot deformities, and poor sensation, walking is less stable. People with CMT1C may trip on small obstacles and fall more often, especially in the dark or on uneven ground.GARD Information Center+1
-
Distal sensory loss in feet – Many people lose or reduce feeling for vibration, light touch, and pain in the feet and toes. They may not notice injuries, small cuts, or pressure areas. Balance is also affected because the brain gets less information from the feet.GARD Information Center+1
-
Paresthesias (tingling and pins-and-needles) – Tingling, buzzing, or “pins and needles” feelings are common in the feet and sometimes the hands. These sensations may be worse at night or after long standing.GARD Information Center+1
-
Neuropathic pain – Some people develop burning, shooting, or electric-like pain in the feet or hands. This is nerve pain and is different from joint or muscle pain. It may limit sleep and daily activities in more severe cases.GARD Information Center+1
-
Hand weakness and loss of fine motor skills – In many patients, especially after years of disease, the small muscles of the hands become weak. Tasks like buttoning shirts, writing, or opening jars become harder.NCBI+1
-
Hand tremor – Some individuals with CMT1C show a fine tremor when holding objects or performing precise movements. This action tremor can affect activities such as drinking from a cup or using utensils.GARD Information Center+1
-
Muscle atrophy in feet and hands – Over time, the muscles in the feet, lower legs, and sometimes hands shrink. The legs may look like an “inverted champagne bottle,” with thin calves and relatively normal thighs.Mayo Clinic+1
-
Reduced or absent tendon reflexes – Reflexes such as the ankle jerk and knee jerk are often reduced or absent on neurological exam. This is a typical sign of peripheral neuropathy.GARD Information Center+1
-
Balance problems – Loss of sensation and weakness combine to disturb balance. Turning quickly, walking on uneven surfaces, and standing with eyes closed may feel unsafe or unstable.NINDS+1
-
Fatigue – Because muscles are weak and nerve signals are less efficient, daily tasks require more effort. Many people with CMT1C feel tired more quickly than their peers, especially after prolonged walking or standing.NINDS+1
-
Slowly progressive course – Symptoms usually worsen slowly over many years. Most people remain able to walk, often with braces or supports, but may need mobility aids later in life. The disease rarely shortens life directly, but it can reduce physical independence.NINDS+2Muscular Dystrophy Association+2
Diagnostic tests
Physical examination
A careful physical and neurological exam is the first and most important step in diagnosing CMT1C or any CMT type.NCBI+1
General neurological examination – The doctor looks for muscle weakness, wasting, changes in tone, involuntary movements (such as tremor), and changes in walking pattern. They check both arms and legs and compare sides. This exam helps decide if the problem is mainly nerve, muscle, spinal cord, or brain.NCBI+1
Muscle strength testing – The doctor tests strength in different muscle groups by asking the patient to push or pull against resistance. Weakness in ankle dorsiflexion, toe extension, and hand muscles supports a diagnosis of distal peripheral neuropathy such as CMT1C.PFM Journal+1
Sensory testing – Light touch, pinprick, vibration, and position sense are checked using simple tools (cotton, pin, tuning fork). In CMT1C, vibration and position sense in the toes and ankles are often reduced, and sometimes other sensory modalities are affected.GARD Information Center+1
Reflex assessment – The doctor taps the tendons at the knee and ankle with a reflex hammer. In CMT1C, deep tendon reflexes are often reduced or absent, especially at the ankles. This finding supports a peripheral neuropathy rather than a brain or spinal cord problem.GARD Information Center+1
Gait and posture observation – The way a person stands and walks gives many clues. The clinician looks for high-stepping gait, foot drop, ankle instability, and difficulty with heel or toe walking. Foot deformities such as high arches and hammertoes are also noted.Mayo Clinic+1
Manual and functional tests
Manual and functional tests are simple bedside tests that check balance, coordination, and fine motor skills. They do not require machines but give important information.NCBI+1
Manual muscle testing (MMT) – The examiner uses their hands to grade muscle strength on a simple scale, for example from 0 (no movement) to 5 (normal strength). In CMT1C, distal muscles usually score lower than proximal muscles. This helps track progression over time.PFM Journal+1
Romberg test – The patient stands with feet together and then closes their eyes. If they sway or fall when they close their eyes, it suggests impaired position sense in the feet due to sensory neuropathy. Many people with CMT show a positive Romberg sign.NCBI+1
Heel-to-toe (tandem) walking – The patient is asked to walk in a straight line, placing the heel of one foot directly in front of the toes of the other. Difficulty or unsteadiness in this task indicates poor balance and coordination, which are common in peripheral neuropathy.PFM Journal+1
Single-leg stance and toe/heel walking – Standing on one leg, walking on toes, and walking on heels test distal strength and balance. People with CMT1C often cannot walk well on their heels due to weakness of the muscles that lift the foot.Mayo Clinic+1
Fine motor tests of the hands – Tasks such as buttoning, picking up small objects, or rapid finger tapping can show subtle hand weakness or tremor. In CMT1C, hand involvement may appear later and can be mild, but these tests help detect it.GARD Information Center+1
Laboratory and pathological tests
Lab and pathology tests help rule out other causes of neuropathy and confirm the genetic basis of CMT1C. Not all of these are needed in every patient.NCBI+1
Basic blood tests – Tests such as blood glucose, vitamin B12, thyroid function, kidney and liver function are often done to look for other common causes of neuropathy. Normal results support a hereditary cause like CMT1C.ARUP Consult+1
Autoimmune and inflammatory markers – Sometimes doctors check markers like ANA or ESR to exclude inflammatory neuropathies. These are usually normal in CMT1C, which is not an autoimmune disease.ARUP Consult+1
Genetic testing for CMT panel – This is the key lab test. Modern CMT gene panels use next-generation sequencing to study many neuropathy genes at once, including LITAF. Finding a pathogenic LITAF mutation in a person with a compatible clinical picture confirms CMT1C.ARUP Consult+2Wiley Online Library+2
Targeted LITAF gene sequencing – In some families where a known LITAF mutation has already been identified, targeted sequencing of that mutation can be used to test relatives. This helps with diagnosis and family planning.Wiley Online Library+1
Copy-number analysis (e.g., MLPA) – Techniques such as MLPA can check for duplications and deletions in genes such as PMP22, which cause CMT1A and related disorders. These tests are mainly used to rule out other CMT1 types when CMT1C is suspected.NCBI+1
Nerve biopsy (sural nerve biopsy) – A small piece of a sensory nerve from the lower leg can be removed and studied under the microscope. In demyelinating CMT, the biopsy may show thin myelin, segmental demyelination, remyelination, and onion bulb formations. Biopsy is now used less often because genetic testing is safer and more specific.NCBI+1
Histological and electron microscopy studies – Detailed microscopic examination of the nerve sample can show hypertrophic changes in the nerve, Schwann cell proliferation, and myelin abnormalities typical for CMT1. These findings support a hereditary demyelinating neuropathy like CMT1C.MalaCards+1
Electrodiagnostic tests
Electrodiagnostic tests measure how well nerves and muscles work. They are essential to show that the neuropathy is demyelinating and length-dependent, which matches CMT1C.NCBI+1
Nerve conduction studies (NCS) – Small electrical shocks are delivered to nerves, and responses are recorded. In CMT1C, motor and sensory nerve conduction velocities are slowed (usually less than about 38 m/s in the arms), reflecting demyelination. The degree of slowing can help separate CMT1 from CMT2 and other neuropathies.Orpha+1
Electromyography (EMG) – A thin needle electrode is inserted into selected muscles to record electrical activity. EMG in CMT1C often shows chronic denervation and reinnervation patterns, meaning the muscle has lost some nerve supply but has partially adapted over time. These changes support a long-standing neuropathy.PFM Journal+1
F-wave and late response studies – These special nerve conduction responses travel up and down the nerve to and from the spinal cord. In demyelinating neuropathies like CMT1C, F-wave latencies are prolonged, showing slowed conduction along the full length of the motor nerve.PFM Journal+1
Imaging tests
Imaging is not the main way to diagnose CMT1C, but it can support the diagnosis or rule out other conditions, especially when symptoms are unusual.ARUP Consult+1
Foot and ankle X-rays – Simple X-rays show bone alignment and foot deformities such as high arches, hammertoes, and joint subluxations. This helps orthopedic and rehabilitation teams plan braces or surgery and documents the skeletal impact of long-term neuropathy.Mayo Clinic+1
Peripheral nerve ultrasound or MRI neurography – In some centers, ultrasound or MRI scans of peripheral nerves are used. In demyelinating CMT, nerves may appear thickened or enlarged (hypertrophic nerves). This imaging can support the diagnosis but is not required if genetic and electrodiagnostic tests are clear.MalaCards+1
Spine and brain MRI (to rule out other causes) – If symptoms are unusual (for example, severe upper motor neuron signs or marked asymmetry), MRI of the spine or brain may be done to rule out other disorders such as spinal cord disease. In pure CMT1C, these scans are usually normal.NINDS+1
General Principles of Treatment for Charcot-Marie-Tooth Neuropathy Type 1C
At present there is no cure and no medicine that can reverse CMT1C. Modern care aims to: keep muscles and joints flexible, prevent deformities, reduce pain and fatigue, and support independence at school, work, and home. Treatment is usually given by a multidisciplinary team including a neurologist, physiotherapist, occupational therapist, orthotist, orthopedic surgeon, and sometimes a pain specialist or psychologist.PMC+1
Physical therapy, braces for the feet and ankles, and carefully planned surgery for severe foot or spine deformity are the main evidence-based options. Medications treat symptoms such as nerve pain or sleep disturbance, not the underlying gene change. Early and regular rehabilitation clearly helps reduce contractures and disability, so treatment is best started soon after diagnosis and then adjusted across life.nhs.uk+2Mayo Clinic+2
Research is looking at gene therapy, gene silencing, and other disease-modifying strategies, but so far these approaches are experimental and not yet standard of care for CMT1C. Patients are sometimes invited into clinical trials, especially in specialized neuromuscular centers.PMC+1
Non-Pharmacological Treatments (Therapies and Others)
1. Physiotherapy (Physical Therapy)
Physiotherapy is a cornerstone of CMT care. A trained therapist designs gentle, low-impact exercises to keep muscles strong and joints flexible. Programs often include stretching, light resistance work, cycling, or swimming. Starting early and doing exercises regularly can slow stiffness, reduce contractures, and preserve walking ability. The therapist also teaches safe movement patterns to protect weak ankles and improve posture and breathing.nhs.uk+2Mayo Clinic+2
2. Stretching and Range-of-Motion Exercises
Daily stretching of calf muscles, hamstrings, and foot muscles helps prevent the ankle and toes from becoming fixed in a bent or twisted position. Simple home routines, such as gentle calf stretches and toe stretches, reduce tightness and make walking less tiring. Regular range-of-motion work protects the joints from contractures and makes later orthotic fitting or surgery easier and more effective.nhs.uk+1
3. Strength Training for Weak Muscles
Supervised, low-load strength training can help preserve muscle power in the legs and hands without over-fatiguing fragile nerves. The focus is on many repetitions with light resistance, not heavy weightlifting. Exercises may include ankle lifts, hip strengthening, or hand grip work. The goal is to support joints, improve walking, and reduce falls, while carefully avoiding overwork weakness.Physiopedia+1
4. Balance and Proprioceptive Training
Because sensory nerves are affected, people with CMT often have poor balance and “do not feel where their feet are.” Balance training uses simple tasks like standing on one leg with support, walking on different surfaces, or using balance boards under supervision. These exercises help the brain rely on vision and remaining sensation to keep the body steady and reduce the risk of falls.ScienceDirect+1
5. Gait Training and Ankle-Foot Orthoses (AFOs)
AFOs are light plastic or carbon braces that support weak ankles and lift the front of the foot. They reduce tripping and “foot drop,” making walking safer and less tiring. Physiotherapists and orthotists work together to train the patient to walk with the new brace, adjust their gait, and choose appropriate shoes. Evidence shows that orthoses improve mobility and reduce falls in many people with CMT.UVA Health+1
6. Occupational Therapy (OT)
OT helps with daily tasks such as dressing, writing, using a computer, cooking, and self-care. The therapist can suggest hand splints, special pens, adapted cutlery, or computer keyboards to make tasks easier. They may also help plan energy-saving strategies, like pacing activities and using equipment instead of pure muscle power, to reduce fatigue and protect joints.Muscular Dystrophy Association+1
7. Custom Footwear and Insoles
High-arched (cavus) feet and clawed toes are common in CMT and can cause pressure points and skin breakdown. Custom shoes and cushioned insoles spread weight more evenly across the foot. Rocker-bottom soles and extra-depth shoes can improve push-off and protect toes. Podiatrists and orthotists adjust footwear over time as deformities change.Physiopedia+1
8. Hand Splints and Functional Aids
Weakness of the small hand muscles can cause poor grip and finger deformity. Lightweight hand splints keep the wrist in a useful position and support finger alignment. Simple gadgets such as jar openers, zipper pulls, and large-handled tools reduce strain. These devices do not change the disease but help people keep independence and reduce frustration.Muscular Dystrophy Association+1
9. Respiratory and Postural Training (for Selected Patients)
Most people with CMT1C do not have serious breathing problems, but those with marked scoliosis or trunk weakness may benefit from breathing exercises and posture training. Therapists teach deep-breathing techniques, supported sitting, and lying positions that ease chest expansion. Good posture can also ease back pain and fatigue during sitting and walking.PubMed+1
10. Pain Psychology and Cognitive-Behavioral Therapy (CBT)
Chronic neuropathic pain and fatigue can affect mood, sleep, and concentration. Pain psychology and CBT help patients reframe pain, learn relaxation and distraction techniques, and improve coping skills. These methods are especially useful when combined with medical treatment and physical activity, and they can reduce the overall impact of pain on daily life.Charcot-Marie-Tooth Association+1
11. Vocational and Educational Rehabilitation
Work, school, and university demands may need adjustment as CMT progresses. Vocational counselors can recommend job modifications, assistive technology, or different roles that fit the person’s physical abilities. At school, children can get extra time for exams, handwriting support, or permission to use laptops or scribes. Early planning helps maintain participation and self-esteem.Muscular Dystrophy Association+1
12. Walking Aids (Cane, Crutches, Walker)
If weakness and balance problems get worse, a cane, crutch, or walker can give extra support. These aids shift some body weight onto the arms and widen the base of support. Using a walking aid is not “giving up”; many people find they can walk further and with more confidence once they have the right device. Proper sizing and training reduce the risk of falls and arm strain.Muscular Dystrophy Association+1
13. Home and Environmental Modifications
Simple changes at home can make life safer: removing loose rugs, adding grab bars in the bathroom, using non-slip mats, improving lighting, and arranging furniture to create clear walking paths. For more severe disability, ramps, stair rails, or stairlifts may be needed. These adjustments reduce falls and help people remain in their own homes longer.Muscular Dystrophy Association+1
14. Podiatry and Foot-Care Programs
Regular nail cutting, callus care, and skin checks on the feet are important because reduced sensation makes injuries harder to notice. A podiatrist can treat corns and calluses safely and advise on pressure-relieving insoles. Good foot care helps prevent ulcers, infections, and pain, especially in people with severe deformities or reduced feeling.Physiopedia+1
15. Aerobic Exercise and Weight Management
Low-impact aerobic activities like swimming, cycling, or walking in safe shoes help maintain heart health, mood, and endurance. Keeping a healthy body weight reduces extra load on already weak feet and ankles. Overweight can make walking and climbing stairs much harder, so a balanced diet and regular activity are key supportive treatments.Physiopedia+1
16. Support Groups and Counseling
Living with a chronic genetic condition can be emotionally difficult. Support groups (online or in person) allow people with CMT and their families to share experiences and coping strategies. Professional counseling may help with anxiety, depression, or grief about physical changes. Emotional support improves quality of life and can make sticking with therapy plans easier.Muscular Dystrophy Association+1
17. Fall-Prevention Programs
Targeted fall-prevention includes teaching safe turning, careful stair use, and how to stand up safely after a fall. Therapists may practice realistic situations, such as walking in crowded places or on uneven ground. Combining strength, balance, footwear advice, and home safety changes can significantly reduce the number of falls and related injuries.ScienceDirect+1
18. School and Workplace Accommodations
Formal accommodations may include accessible parking, adjustable desks, extra rest breaks, and permission to sit rather than stand. In schools, accommodations can include elevator access, lockers near classrooms, and reduced need to carry heavy bags. These changes allow people with CMT1C to participate fully without overloading their muscles and nerves.Charcot-Marie-Tooth Association+1
19. Assistive Technology (Keyboards, Voice Software, Wheelchairs)
Keyboards with large keys, speech-to-text software, adapted mice, and powered wheelchairs or scooters are examples of assistive technology. They reduce the physical effort needed for writing, mobility, and communication. The goal is not to “replace” walking or hand use but to preserve independence and reduce fatigue as the disease slowly progresses.Muscular Dystrophy Association+1
20. Genetic Counseling for Families
Because CMT1C is usually autosomal dominant, genetic counseling is important for people planning a family. Counselors explain inheritance patterns, testing options for relatives, and possible reproductive choices. Understanding the genetic risk helps families make informed decisions and can reduce anxiety about the future.MalaCards+1
Drug Treatments for Symptoms in Charcot-Marie-Tooth Neuropathy Type 1C
Before listing medicines, it is vital to say: there is no drug approved to cure or slow CMT1C itself. Medicines are used mainly for neuropathic pain, muscle cramps, mood problems, and sleep issues. Many of these medicines are approved for other forms of neuropathic pain, such as diabetic peripheral neuropathy or post-herpetic neuralgia, and may be used off-label in CMT. All of them must be prescribed and monitored by a doctor; doses below are general adult examples, not instructions, and are not for self-treatment, especially not for teenagers.PMC+2Mayo Clinic+2
1. Duloxetine (Cymbalta® – SNRI antidepressant)
Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI) approved for diabetic peripheral neuropathic pain as well as depression and anxiety. A common adult dose for neuropathic pain is 60–120 mg once daily, with the doctor starting low and increasing slowly. It works by boosting serotonin and norepinephrine in pain pathways in the brain and spinal cord, which reduces pain signaling. Common side effects include nausea, sleepiness, dry mouth, constipation, and sweating.FDA Access Data+2FDA Access Data+2
2. Pregabalin (Lyrica® – α2-δ calcium channel ligand)
Pregabalin is approved for neuropathic pain linked to diabetic neuropathy, post-herpetic neuralgia, and spinal cord injury. Adults often start at 150 mg per day, split into two or three doses, with gradual increases up to 300–600 mg/day depending on response and kidney function. It binds to the α2-δ subunit of voltage-gated calcium channels, reducing release of excitatory neurotransmitters and calming overactive nerve firing. Side effects include dizziness, drowsiness, weight gain, and swelling of the legs.FDA Access Data+2FDA Access Data+2
3. Gabapentin (Neurontin®, Gralise®, Horizant® – anticonvulsant/neuropathic pain agent)
Gabapentin is approved for post-herpetic neuralgia and certain seizure types. For neuropathic pain, adults may start at 300 mg and gradually increase, often to 900–1800 mg/day in divided doses, as tolerated. It also binds to α2-δ calcium channel subunits and reduces abnormal nerve signaling. Drowsiness, dizziness, and coordination problems are common side effects, so doctors adjust doses carefully, especially in people with balance problems like CMT.FDA Access Data+2FDA Access Data+2
4. Tapentadol Extended-Release (Nucynta® ER – opioid plus NRI)
Tapentadol ER is an opioid analgesic with additional norepinephrine reuptake inhibition, approved for severe and persistent neuropathic pain associated with diabetic peripheral neuropathy when other options are not adequate. Doctors start at a low twice-daily dose and increase slowly, monitoring for benefit and harm. It acts on opioid receptors and boosts norepinephrine signaling to block pain. Risks include addiction, tolerance, constipation, sleepiness, and breathing problems, so it is reserved for carefully selected adults.FDA Access Data+2FDA Access Data+2
5. Topical Lidocaine Patches (Lidoderm®, ZTlido®, Bondlido® – local anesthetic)
Lidocaine 5% or similar patches are approved for pain from post-herpetic neuralgia and are sometimes used off-label for focal neuropathic pain in the feet. The patch is applied to intact skin over painful areas for a limited number of hours each day, according to the product label. Lidocaine blocks sodium channels in nerve endings, reducing pain signals from the skin without significant whole-body effects when used correctly. Skin irritation and numbness are the main side effects.FDA Access Data+4FDA Access Data+4FDA Access Data+4
6. Capsaicin 8% Patch (Qutenza® – high-dose topical capsaicin)
Qutenza is a clinic-applied capsaicin patch approved for neuropathic pain from post-herpetic neuralgia and diabetic peripheral neuropathy. A healthcare professional applies the patch to the painful area for a set time (for example 30–60 minutes), and the effect can last for weeks to months. Capsaicin over-stimulates and then “turns down” pain fibers by acting on TRPV1 receptors, which can reduce burning pain. It may cause temporary burning or redness at the site, so local anesthetic is often used beforehand.FDA Access Data+2FDA Access Data+2
7. Simple Analgesics (Paracetamol/Acetaminophen)
Acetaminophen is widely used for mild joint or muscle pain and fever. Although it does not treat neuropathic pain directly, it can help with musculoskeletal aches related to abnormal gait, foot deformities, or overuse. Doses must stay within the safe daily limit to avoid liver damage, and any regular use should be supervised by a doctor, especially if other medicines also affect the liver.Mayo Clinic+1
8. Non-steroidal Anti-Inflammatory Drugs (NSAIDs, e.g., ibuprofen, naproxen)
NSAIDs reduce inflammation and can help with joint or soft-tissue pain from altered walking mechanics or surgery. They are less effective for pure nerve pain but often used in combination with neuropathic-pain medicines. Typical adult dosing is limited by risk of stomach ulcers, kidney injury, and heart effects, so they are used at the lowest effective dose for the shortest time.Mayo Clinic+1
9. Tricyclic Antidepressants (e.g., Amitriptyline, Nortriptyline – off-label)
Low-dose tricyclic antidepressants are commonly used off-label for neuropathic pain, especially at night. They block reuptake of serotonin and norepinephrine, and also have sodium-channel effects, dampening pain pathways. Doses for pain are usually much lower than for depression and are taken once in the evening. Side effects include dry mouth, constipation, drowsiness, and sometimes heart rhythm changes, so heart history is checked before use.Mayo Clinic+1
10. Other SNRIs or SSRIs (e.g., Venlafaxine – off-label)
Some clinicians use other SNRIs or SSRIs for neuropathic pain when duloxetine is not tolerated, although evidence is weaker. They work mainly by boosting serotonin and norepinephrine in pain pathways and may also help treat depression or anxiety that often accompany chronic pain. Side effects vary but can include nausea, sleep disturbance, and sexual dysfunction. They must not be combined carelessly with other serotonergic drugs because of the risk of serotonin syndrome.FDA Access Data+1
11. Tramadol (weak opioid with SNRI properties)
Tramadol is sometimes used for moderate neuropathic pain when first-line therapies are not enough. It has both weak opioid activity and serotonin/norepinephrine reuptake inhibition. Doctors start with small doses and monitor closely for drowsiness, dizziness, constipation, and rare but serious problems such as dependence or serotonin syndrome when combined with antidepressants. It is not suitable for everyone and is generally a second- or third-line option.FDA Access Data+1
12. Muscle Relaxants (e.g., Baclofen) for Cramps and Spasticity
Some people with CMT have painful muscle cramps or stiffness, especially at night. Baclofen and similar drugs act on GABA receptors in the spinal cord to relax muscles. They may be used at low doses in adults if cramps are severe, but side effects include drowsiness, dizziness, and weakness, which can worsen balance. Careful dosing and review are essential.ScienceDirect+1
Because you are a teenager, it is very important: never start, stop, or change any of these medicines without your neurologist and a responsible adult. The information here is educational and based on drug labels and neuropathic-pain guidelines, not personal medical advice.Charcot-Marie-Tooth Association+1
Dietary Molecular Supplements
Evidence for supplements in CMT1C is limited. Most data come from studies in diabetic neuropathy or other nerve conditions. Any supplement can interact with medicines, so always discuss with a doctor first.
1. Vitamin B12 (Cobalamin)
Vitamin B12 is essential for healthy myelin and normal nerve function. Deficiency can itself cause neuropathy, so checking and correcting low B12 is important in any person with nerve symptoms. Treatment can be with high-dose tablets or injections, depending on absorption, and typical adult daily intakes are 2.4 µg for prevention, with much higher doses to treat deficiency. B12 can improve nerve function and may reduce neuropathic pain when deficiency is present, but it does not cure genetic CMT.Cleveland Clinic+2PubMed+2
2. B-Complex (B1, B6, B9, B12 – with caution on B6)
B vitamins support energy production and nerve health. In people who are deficient, replacing vitamins like thiamine (B1) and folate (B9) can help nerve repair. However, too much vitamin B6 over long periods can damage nerves, so doses must stay within safe limits. A balanced B-complex under medical supervision may support general nerve health but is not a specific treatment for CMT1C.Verywell Health+1
3. Alpha-Lipoic Acid (ALA)
ALA is an antioxidant involved in energy production within mitochondria. Clinical trials in diabetic neuropathy show that ALA can improve nerve conduction and reduce burning, tingling, and numbness in some patients, likely by reducing oxidative stress and inflammation in nerves. Typical studied doses range around 600 mg/day, but dose and duration should be set by a doctor. There is no direct trial in CMT1C, so any use is extrapolated with caution.PMC+2MDPI+2
4. Acetyl-L-Carnitine
Acetyl-L-carnitine helps transport fatty acids into mitochondria and may support nerve energy metabolism. Studies in some types of neuropathy suggest it might reduce pain and support nerve regeneration, though data are mixed. Adult doses in studies vary (often 500–2000 mg/day), and possible side effects include nausea and restlessness. Evidence in CMT is limited, so it is considered experimental supportive therapy.Verywell Health+1
5. Omega-3 Fatty Acids (Fish Oil or Plant Sources)
Omega-3 polyunsaturated fatty acids have anti-inflammatory effects and are important for nerve membrane structure. Animal and early human studies suggest omega-3s can reduce nerve damage and might help neuropathic pain, but large clinical trials show mixed results, with some finding little benefit for diabetic neuropathy. Typical supplemental adult doses are 1–3 g/day of EPA+DHA, but quality and interactions (for example with blood thinners) must be considered.European Medical Journal+3PMC+3Dove Medical Press+3
6. Coenzyme Q10 (CoQ10)
CoQ10 is a mitochondrial antioxidant that helps produce energy in cells. It has shown benefit in some mitochondrial diseases and may support muscle function, although it is not FDA-approved for these uses. Typical studied doses range from 100–300 mg/day in adults. In theory, CoQ10 might help reduce oxidative stress in nerves and muscles in CMT, but evidence is indirect, so its use should be individualized.PMC+2ScienceDirect+2
7. Vitamin D
Vitamin D supports bone health and muscle function. Low vitamin D is common in people with mobility problems and can worsen weakness and fracture risk. Supplement doses depend on blood levels and may range from 800–2000 IU/day or more under medical guidance. While it does not treat CMT1C directly, keeping vitamin D in the normal range helps reduce additional bone and muscle problems.nhs.uk+1
8. Magnesium
Magnesium is involved in muscle relaxation and nerve signaling. In some people, correcting low magnesium can reduce muscle cramps and improve sleep. Usual supplemental doses are often 200–400 mg/day in adults, depending on kidney function. Too much magnesium can cause diarrhea or, rarely, serious problems in people with kidney disease, so medical advice is necessary.Verywell Health+1
9. Curcumin (Turmeric Extract)
Curcumin from turmeric has anti-inflammatory and antioxidant properties. Preclinical studies suggest it may protect nerves from oxidative damage, but human evidence in neuropathy is still limited. It is often taken with a “bio-enhancer” like piperine to improve absorption. Doses and quality vary widely, and it should be used cautiously in people on blood thinners.Verywell Health+1
10. Mixed Antioxidant Formulas
Some supplements combine vitamins C and E, selenium, alpha-lipoic acid, and other antioxidants. The idea is to reduce oxidative stress, which may contribute to nerve injury. Clinical data are mixed, and such products are not regulated like medicines. For people who eat a varied diet rich in fruits and vegetables, extra antioxidant pills may not add much benefit. Any use should be checked with a clinician.Verywell Health+1
Regenerative and Stem-Cell-Related Drug Approaches (Experimental)
Right now, there are no approved stem-cell or regenerative drugs specifically for Charcot-Marie-Tooth neuropathy type 1C. Research is exploring gene therapy, gene editing, and neurotrophic factors in different CMT subtypes, but these are mainly in laboratory or early clinical-trial stages. Dosing, long-term safety, and real-world benefit are not yet established.PMC+1
Experimental ideas include using viral vectors to correct or silence faulty genes, delivering growth factors to support myelin repair, or transplanting stem cells that might become supporting cells in peripheral nerves. For now, these approaches are only available, if at all, inside controlled research studies with strict ethical and safety monitoring. Anyone interested should talk with a neuromuscular specialist about reputable trials and avoid unregulated “stem-cell clinics” that offer expensive but unproven treatments.PMC+1
Surgeries Used in Charcot-Marie-Tooth Neuropathy
1. Foot Deformity Correction (Cavovarus Reconstruction)
Many people with CMT develop high-arched (cavus) feet, heel varus (tilted inward), and clawed toes. Surgery aims to create a more plantigrade (flat and stable) foot. Procedures can include plantar fascia release, tendon transfers to rebalance weak and strong muscles, and bone cuts (osteotomies) to realign the foot. These operations can improve walking, reduce pain, and decrease falls when conservative measures are not enough.PMC+2PMC+2
2. Tendon Transfer Procedures
In tendon transfer, a stronger tendon is moved to help a weaker movement, such as lifting the foot. For example, part of the posterior tibial tendon can be moved to the top of the foot to assist dorsiflexion. These procedures help rebalance muscle forces and can reduce deformity recurrence after bone corrections. They are usually combined with other foot surgeries to achieve long-lasting alignment.PMC+2ScienceDirect+2
3. Osteotomy and Limited Fusion
Surgeons may perform calcaneal osteotomy (cutting and shifting the heel bone) or midfoot osteotomies to correct rigid deformities. In severe, rigid cases, limited joint fusion (arthrodesis) may be used to stabilize the foot in a good position. The goal is to create a stable, pain-free foot that fits into shoes and allows safer walking, not to make the foot “normal.”www.elsevier.com+2Journal of the Foot & Ankle+2
4. Toe Deformity Surgery (e.g., Jones Procedure)
Clawed big toes and small toes can cause pressure, pain, and shoe problems. Procedures such as extensor hallucis longus tendon transfer (Jones procedure) and small joint corrections can straighten the toes and redistribute pressure. Correcting toe deformities is often done at the same time as cavus surgery to improve overall foot function.PubMed+2ResearchGate+2
5. Spinal Fusion for Scoliosis (Selected Patients)
Some people with CMT develop significant scoliosis that does not respond to bracing. In these cases, posterior spinal fusion with metal rods and screws may be recommended to prevent progression, improve posture, and reduce pain. This is major surgery and is only considered when potential benefits clearly outweigh risks. Careful pre-operative evaluation and neuromonitoring during surgery are standard.Hospital for Special Surgery+3PubMed+3Charcot-Marie-Tooth Disease+3
Prevention and Lifestyle Measures
-
Avoid Nerve-Toxic Medicines – Some chemotherapy drugs and other medicines are known to damage peripheral nerves. People with CMT should show every new doctor a list of potentially harmful drugs and ask for safer alternatives when possible.Muscular Dystrophy Association+1
-
Protect Feet from Injury – Wear well-fitting shoes, avoid walking barefoot on rough surfaces, and check feet regularly for blisters or cuts, because reduced feeling may hide injuries.Physiopedia+1
-
Maintain Healthy Weight – Extra body weight puts more stress on weak feet and joints and makes moving harder. A balanced diet and regular activity help keep weight in a comfortable range.Mayo Clinic+1
-
Keep Active but Avoid Over-Exertion – Gentle, regular exercise is beneficial, but pushing through strong pain or extreme fatigue can worsen symptoms. The best rule is “little and often,” guided by a physiotherapist.Physiopedia+1
-
Prevent Falls – Use braces, walking aids, and home safety changes as recommended. Simple steps like good lighting, non-slip shoes, and clearing clutter make a big difference.ScienceDirect+1
-
Stop Smoking – Smoking damages blood vessels and can worsen nerve health and wound healing. Quitting improves general health and may help nerves work better.nhs.uk+1
-
Avoid or Strictly Limit Alcohol – Alcohol in high amounts is toxic to nerves and can cause its own neuropathy. For a teenager, the safest advice is no alcohol at all.nhs.uk+1
-
Manage Other Health Conditions – Diabetes, vitamin deficiencies, and thyroid problems can all worsen neuropathy; good control of these conditions helps protect remaining nerve function.nhs.uk+1
-
Use Regular Follow-Up – Seeing the neuromuscular team at agreed intervals allows early detection of new problems such as scoliosis or increased deformity, when conservative treatments still work best.Muscular Dystrophy Association+1
-
Seek Emotional Support – Taking care of mental health helps with long-term self-care and prevention. Low mood and anxiety can lead to inactivity and poorer physical outcomes.Muscular Dystrophy Association+1
When to See Doctors
You should see a doctor or neuromuscular specialist regularly, even when you feel stable, to monitor nerve function, foot shape, posture, and overall health. However, certain warning signs mean you should seek medical help sooner:
-
New or rapidly worsening weakness in your feet, legs, or hands.
-
Sudden increase in falls, tripping, or difficulty walking.
-
Severe new pain, burning, or numbness that does not settle.
-
Skin sores, ulcers, or infections on the feet, especially if you do not feel them well.
-
Noticeable changes in back shape, such as a new curve or uneven shoulders.
-
Breathing problems, chest tightness, or unexplained fatigue.
Early medical review allows faster adjustment of braces, therapy programs, or medicines, and timely referral to orthopedic or pain specialists when needed.Mayo Clinic+2Muscular Dystrophy Association+2
What to Eat and What to Avoid
-
Eat a Balanced Plate – Include vegetables, fruits, whole grains, lean protein (fish, eggs, pulses, lean meat), and healthy fats at most meals to support overall health and muscle function.nhs.uk+1
-
Choose Healthy Fats – Prefer fats from fish, nuts, seeds, and plant oils, which provide omega-3 and omega-6 fatty acids, rather than large amounts of fried and fast foods rich in trans-fats.PMC+1
-
Ensure Enough B12 and Other B-Vitamins – Eat foods like fish, eggs, dairy, and fortified cereals, or use supplements if advised, to avoid deficiency-related nerve damage. Vegetarians and vegans may especially need B12 supplements under medical guidance.Cleveland Clinic+1
-
Keep Vitamin D and Calcium Adequate – Include dairy, fortified foods, and safe sunlight exposure, or supplements if prescribed, to protect bones weakened by reduced activity.nhs.uk+1
-
Limit Sugary Foods and Drinks – Too much sugar can promote weight gain and increase the risk of diabetes, which itself damages nerves. Choose water or unsweetened drinks instead of sugary sodas.nhs.uk+1
-
Avoid Excessive Salt and Highly Processed Food – Very salty snacks and processed meals can raise blood pressure and harm heart and kidney health, indirectly affecting nerve and muscle performance.nhs.uk+1
-
Avoid Alcohol (Especially in Teens) – As mentioned, alcohol is harmful to nerves, so the safest option for a young person with CMT1C is not to drink at all.nhs.uk+1
-
Stay Well Hydrated – Drinking enough water throughout the day supports circulation, muscle function, and overall energy levels, which helps you participate in therapy and exercise.nhs.uk+1
-
Be Cautious with Unproven “Nerve Cure” Supplements – Many products advertise nerve regeneration but lack strong evidence and are not well regulated. Always check with a doctor before trying new supplements.Verywell Health+1
-
Work with a Dietitian if Needed – A dietitian familiar with neuromuscular conditions can tailor a plan to your preferences, culture, and body needs, making healthy eating more realistic and enjoyable.Verywell Health+1
Frequently Asked Questions (FAQs)
1. Is CMT1C curable?
No, there is currently no cure for CMT1C. Treatments focus on reducing symptoms, preventing complications, and keeping you as active and independent as possible. Researchers are working on gene-based and regenerative therapies, but these are not yet routine care.PMC+1
2. Will I end up in a wheelchair?
Disease severity varies a lot. Many people with CMT1C remain able to walk with braces and therapy for many years. Some may later use a wheelchair or scooter for long distances to save energy and reduce falls, but this does not always mean complete loss of walking.PMC+2Charcot-Marie-Tooth Association+2
3. Can exercise make my nerves worse?
Gentle, well-planned exercise is usually helpful, not harmful. Over-exertion and pushing through strong pain or extreme fatigue are not advised. Working with a physiotherapist ensures exercises are safe and adapted to your abilities.Physiopedia+1
4. Are there special shoes for CMT?
Yes. Extra-depth shoes, firm heel counters, and soles that work well with AFOs are often recommended. Custom insoles and braces are fitted by orthotists and podiatrists to match your foot shape and walking pattern.Physiopedia+1
5. Can diet or vitamins cure CMT1C?
No diet or vitamin can fix the genetic cause of CMT1C. However, treating deficiencies (for example vitamin B12 or vitamin D) and keeping a healthy weight support nerve and muscle health and may prevent additional problems.Cleveland Clinic+2Verywell Health+2
6. Is CMT1C life-threatening?
Most people with CMT1C have a normal life span, especially with good care. Serious complications such as severe scoliosis or breathing problems are less common but still require monitoring and early treatment if they appear.PubMed+1
7. Should my family members be tested?
Because CMT1C is usually autosomal dominant, close relatives may benefit from clinical or genetic testing, especially if they have symptoms. Genetic counseling can help families decide who should be tested and when.MalaCards+1
8. Can I have children?
Most people with CMT1C can have children. Each child usually has a 50% chance of inheriting the faulty gene if one parent is affected, but severity is hard to predict. Genetic counseling can explain options, including prenatal or pre-implantation genetic testing in some countries.MalaCards+1
9. Are there medicines I must avoid?
Some drugs are known to be particularly risky in people with CMT or other neuropathies, including certain chemotherapy agents and high-dose, long-term nitrofurantoin, among others. Your neuromuscular clinic often provides a list, and every new prescriber should be told about your CMT.Muscular Dystrophy Association+1
10. Does CMT affect the brain?
CMT mainly affects peripheral nerves, not the brain. Thinking and learning are usually normal. However, chronic pain, fatigue, and emotional stress can affect concentration and mood, which is why mental health support is important.Muscular Dystrophy Association+1
11. Can surgery make my CMT worse?
Foot and spine surgeries do not change the underlying nerve problem, but they can improve alignment and function. As with any surgery, there are risks, and recovery can be long. Choosing surgeons experienced with CMT and planning rehabilitation carefully helps reduce complications.PMC+2PubMed+2
12. Is pain always part of CMT1C?
Not everyone with CMT1C has strong pain. Some have mostly weakness and deformity, while others have burning neuropathic pain, cramps, or musculoskeletal pain. Pain can often be improved with a combination of medicines, physical therapy, and psychological approaches.Mayo Clinic+1
13. Are there official guidelines I should follow?
Several professional groups and patient organizations have guidance on managing CMT, emphasizing multidisciplinary care, early rehabilitation, and individualized orthotic and surgical decisions. Your neurologist can point you to guidelines relevant in your country.PMC+1
14. Can I participate in sports?
Many people with mild CMT1C enjoy low-impact sports like swimming, cycling, or yoga. High-impact, contact, or very uneven-ground sports can carry a higher risk of sprains or fractures. A physiotherapist can help choose safe activities and braces that protect your ankles.Physiopedia+1
15. As a teenager, what is the most important thing I should remember?
The most important things are: keep moving with safe exercise, use braces or aids if they help, protect your feet, avoid smoking and alcohol, and stay in regular contact with your neuromuscular team. Do not start or stop any medicine or supplement on your own—always talk to your doctor and a trusted adult first. With good support, many people with CMT1C study, work, and live full, active lives.Muscular Dystrophy Association+2Mayo Clinic+2
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: December 25, 2025.